0001562180-23-004542.txt : 20230526
0001562180-23-004542.hdr.sgml : 20230526
20230526173439
ACCESSION NUMBER: 0001562180-23-004542
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230524
FILED AS OF DATE: 20230526
DATE AS OF CHANGE: 20230526
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Glatch Lisa
CENTRAL INDEX KEY: 0001339795
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35229
FILM NUMBER: 23970487
MAIL ADDRESS:
STREET 1: EVOQUA WATER TECHNOLOGIES CORP.
STREET 2: 210 SIXTH AVENUE
CITY: PITTSBURGH
STATE: PA
ZIP: 15222
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xylem Inc.
CENTRAL INDEX KEY: 0001524472
STANDARD INDUSTRIAL CLASSIFICATION: PUMPS & PUMPING EQUIPMENT [3561]
IRS NUMBER: 452080495
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 WATER STREET SE
CITY: WASHINGTON
STATE: DC
ZIP: 20003
BUSINESS PHONE: 202-869-9150
MAIL ADDRESS:
STREET 1: 301 WATER STREET SE
CITY: WASHINGTON
STATE: DC
ZIP: 20003
FORMER COMPANY:
FORMER CONFORMED NAME: ITT WCO, Inc.
DATE OF NAME CHANGE: 20110628
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0407
4
2023-05-24
false
0001524472
Xylem Inc.
XYL
0001339795
Glatch Lisa
C/O XYLEM INC.
301 WATER STREET SE
WASHINGTON
DC
20003
true
false
false
false
false
Common Stock
2023-05-24
4
A
false
1633.00
0.00
A
1633.00
D
Common Stock
2023-05-24
4
A
false
5963.00
0.00
A
7596.00
D
Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) and sub-pool of shares from the Evoqua Water Technologies 2017 Equity Plan assumed by Xylem Inc. as part of the merger of Xylem Inc. and Evoqua Water Technologies Corp. ("Evoqua") on May 24, 2023 (the "Merger"), that are scheduled to vest in full on the trading day prior to the 2024 Annual Meeting of Shareholders.
Received in exchange for 12,427 shares of Evoqua common stock in connection with the Merger. On May 24, 2023, the effective date of the Merger, the closing price of Evoqua's common stock was $49.88 per share, and the closing price of Xylem Inc.'s common stock was $101.06 per share.
/s/ Callie Plant, by power of attorney for Lisa Glatch
2023-05-26
EX-24
2
glatch_poa.txt
GLATCH_POA
POWER OF ATTORNEY
The undersigned, Lisa Glatch, does hereby nominate constitute and
appoint each of Kelly O'Shea, Juliene Patton, Callie Plant and Dorothy Capers
as his/her/their true and lawful attorneys and agents to do any and all acts
and things and execute and file any and all instruments which said attorneys
and agents may deem necessary or advisable to enable the undersigned (in his/
her/their individual capacity or in any other capacity) to comply with the
Securities Exchange Act of 1934 (the "34 Act") and the Securities Act of 1933
(the "33 Act") and any requirements of the Securities and Exchange Commission
(the "SEC") in respect thereof, in connection with the preparation, execution
and/or filing of (i) any report or statement of beneficial ownership or changes
in beneficial ownership of securities of Xylem Inc., an Indiana corporation
(the "Company"), that the undersigned (in his/her/their individual capacity or
in any other capacity) may be required to file pursuant to Section 16(a) of the
34 Act, including any repo rt or statement on Form 3, Form 4 or Form 5, or to
any amendment thereto, (ii) any report or notice required under Rule 144 of the
33 Act, including Form 144, or any amendment thereto relating to the
undersigned's role with, or beneficial ownership of, the Company's securities,
and (iii) any and all other documents or instruments that may be necessary or
desirable in connection with or in furtherance of any of the foregoing,
including Form ID, or any amendments thereto, and any other documents necessary
or appropriate to obtain codes and passwords enabling the undersigned to make
electronic filings with the SEC of reports required pursuant to Section 16(a)
of the 34 Act or any rule or regulation of the SEC, such power and authority to
extend to any form or forms adopted by the SEC in lieu of or in addition to any
of the foregoing and to include full power and authority to sign the
undersigned's name in his/her/their individual capacity or otherwise, hereby
ratifying and confirming all that said attorneys and agents, or any of them,
shall do or cause to be done by virtue thereof.
This authorization shall supersede all prior authorizations to act for the
undersigned with respect to securities of the Company in such matters, which
prior authorizations are hereby revoked, and shall remain in effect until the
undersigned is no longer required to file Form 3, 4 or 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company
unless earlier revoked, by the undersigned in a signed writing delivered to the
foregoing attorneys in fact.
IN WITNESS WHEREOF, I have hereunto set my hand this 10th day of May 2023.
_____________________________
/s/ Lisa Glatch